Verition Fund Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $891K | Buy |
31,367
+21,900
| +231% | +$622K | ﹤0.01% | 1929 |
|
|
2025
Q1 | $279K | Sell |
9,467
-77,635
| -89% | -$2.29M | ﹤0.01% | 2254 |
|
|
2024
Q4 | $2.53M | Buy |
87,102
+66,686
| +327% | +$1.94M | 0.01% | 1056 |
|
|
2024
Q3 | $938K | Buy |
20,416
+13,011
| +176% | +$598K | ﹤0.01% | 1359 |
|
|
2024
Q2 | $302K | Buy |
+7,405
| New | +$302K | ﹤0.01% | 1715 |
|
|
2023
Q3 | – | Sell |
-30,460
| Closed | -$338K | – | 2228 |
|
|
2023
Q2 | $338K | Buy |
+30,460
| New | +$338K | ﹤0.01% | 1274 |
|